Embedded Files
Welcome and Opening Remarks
Welcome and Opening Remarks
8:30 am US CST
Prasanna Krishnamurthy, MVSc, PhD (USA)
Prasanna Krishnamurthy, MVSc, PhD (USA)
Petra Kienesberger, MSc, PhD (Canada)
Petra Kienesberger, MSc, PhD (Canada)
KeyNote Presentation
KeyNote Presentation
Susan Howlett, PhD
Susan Howlett, PhD
Dalhousie University, Canada
8:40 am US CST
Frailty sows the seeds for late life cardiovascular disease differentially in males and females
Frailty sows the seeds for late life cardiovascular disease differentially in males and females
Session 1 : Sex differences in cardiovascular disease
Session 1 : Sex differences in cardiovascular disease
Moderators
Moderators
Helen Collins, PhD, FAHA
Helen Collins, PhD, FAHA
University of Louisville, USA
Prasanna Krishnamurthy, DVM, MVSc, PhD, FAHA
Prasanna Krishnamurthy, DVM, MVSc, PhD, FAHA
University of Alabama at Birmingham, USA
Iain Greenwood, PhD, FBPhS, SFHEA
Iain Greenwood, PhD, FBPhS, SFHEA
St George's University of London, UK
9:00 am US CST
Sexual dimorphism in arterial Kv7 channels
Sexual dimorphism in arterial Kv7 channels
Glen Pyle, PhD
Glen Pyle, PhD
University of Guelph, Canada
9:15 am US CST
Reading the Fine Print for Women’s Heart Health: Identifying molecular changes in the heart as mechanisms for cardiovascular disease risk
Reading the Fine Print for Women’s Heart Health: Identifying molecular changes in the heart as mechanisms for cardiovascular disease risk
Beshay Zordoky, PhD
Beshay Zordoky, PhD
University of Minnesota, USA
9:30 am US CST
Sex Differences of Cardiac Hypertrophy and Drug-induced Cardiotoxicity
Sex Differences of Cardiac Hypertrophy and Drug-induced Cardiotoxicity
Jennifer Thompson, PhD
Jennifer Thompson, PhD
University of Calgary, Canada
9:45 am US CST
The intrauterine environment, sex and adipose plasticity throughout the life course
The intrauterine environment, sex and adipose plasticity throughout the life course
Break
Break
KeyNote Presentations
KeyNote Presentations
Ren-Ke Li, MD, PhD
Ren-Ke Li, MD, PhD
University of Toronto, Canada
10:10 am US CST
Conductive Biomaterial, A new technology for cardiac repair
Conductive Biomaterial, A new technology for cardiac repair
Palaniappan Sethu, PhD
Palaniappan Sethu, PhD
University of Alabama at Birmingham, USA
10:30 am US CST
Cardiac Tissue Chips for Cardiovascular Research
Cardiac Tissue Chips for Cardiovascular Research
Session 2 : Biomaterials, cardiac remodeling & repair
Session 2 : Biomaterials, cardiac remodeling & repair
Moderators
Moderators
Mingtao Zhao, DVM, PhD
Mingtao Zhao, DVM, PhD
The Ohio State University, USA
Sanjiv Dhingra, PhD, FAHA, FCVS
Sanjiv Dhingra, PhD, FAHA, FCVS
University of Manitoba, Canada
Dhandapany Perundurai, PhD
Dhandapany Perundurai, PhD
Institute for Stem Cell Science and Regenerative Medicine (inStem), India
10:50 pm US CST
Gene discovery and functional validation using stem cells and animal models for cardiomyopathy
Gene discovery and functional validation using stem cells and animal models for cardiomyopathy
Huaxiao "Adam" Yang, PhD
Huaxiao "Adam" Yang, PhD
University of North Texas, USA
11:05 pm US CST
Modeling Cardiovascular Development and Disease with Human Pluripotent Stem Cells in 2D and 3D Models
Modeling Cardiovascular Development and Disease with Human Pluripotent Stem Cells in 2D and 3D Models
Xin Wang, MD, PhD
Xin Wang, MD, PhD
The University of Manchester, UK
11:20 pm US CST
Investigating Organelle Signalling Underlying Heart Failure: A Focus on Pak Family Kinases
Investigating Organelle Signalling Underlying Heart Failure: A Focus on Pak Family Kinases
Susmita Sahoo, PhD
Susmita Sahoo, PhD
Icahn School of Medicine at Mount Sinai, USA
11:35 pm US CST
Extracellular Vesicles in Cardiovascular Nanomedicine
Extracellular Vesicles in Cardiovascular Nanomedicine
Break
Break
KeyNote Presentation
KeyNote Presentation
Lorrie Kirshenbaum, PhD
Lorrie Kirshenbaum, PhD
University of Manitoba, Canada
12:20 pm US CST
TRAF2-NF-kB Signaling in Doxorubicin Cardiomyopathy
TRAF2-NF-kB Signaling in Doxorubicin Cardiomyopathy
Session 3 : Cardio-oncology & autophagy in the heart
Session 3 : Cardio-oncology & autophagy in the heart
Moderators
Moderators
Guochang Fan, PhD
Guochang Fan, PhD
University of Cincinnati, USA
Rajasingh Johnson, MPhil, PhD
Rajasingh Johnson, MPhil, PhD
University of Tennesse, USA
Gopinath Sutendra, PhD
Gopinath Sutendra, PhD
University of Alberta, Canada
12:40 pm US CST
Targeting Cysteine Oxidation as a Therapeutic Platform for Cardio-Oncology
Targeting Cysteine Oxidation as a Therapeutic Platform for Cardio-Oncology
Inna Rabinovich-Nikitin, PhD
Inna Rabinovich-Nikitin, PhD
University of Manitoba, Canada
12:55 pm US CST
Interplay between clock genes and autophagy pathways in the heart
Interplay between clock genes and autophagy pathways in the heart
Yajing Wang, MD, PhD
Yajing Wang, MD, PhD
University of Alabama at Birmingham, USA
01:10 pm US CST
CTRP9's cardioprotective role involves restoring balanced mitophagic flux by enhancing cathepsin activity
CTRP9's cardioprotective role involves restoring balanced mitophagic flux by enhancing cathepsin activity
Wei Guo, PhD
Wei Guo, PhD
University of Wisconsin-Madison, USA
01:25 pm US CST
Biomolecular condensates in the cytoplasm of cardiomyocytes are new causative for heart failure
Biomolecular condensates in the cytoplasm of cardiomyocytes are new causative for heart failure
Break
Break
KeyNote Presentation
KeyNote Presentation
John Elrod, PhD
John Elrod, PhD
Temple University, USA
01:50 pm US CST
Discovery of an essential regulator of mitochondrial calcium efflux
Discovery of an essential regulator of mitochondrial calcium efflux
Session 4 : Cardiac mitochondria in heart failure
Session 4 : Cardiac mitochondria in heart failure
Moderators
Moderators
Joseph Gordon, PhD
Joseph Gordon, PhD
University of Manitoba, Canada
Petra Kienesberger, PhD
Petra Kienesberger, PhD
Dalhousie University, Canada
Kimberly Dunham-Snary, MPS, PhD
Kimberly Dunham-Snary, MPS, PhD
Queen's University, Canada
02:10 pm US CST
Mitochondrial DNA signature modulates gene expression and metabolism in mice
Mitochondrial DNA signature modulates gene expression and metabolism in mice
Lilei Zhang, MD, PhD
Lilei Zhang, MD, PhD
Baylor College of Medicine, USA
02:25 pm US CST
Novel pan-ERR agonists ameliorate heart failure through enhancing cardiac fatty acid metabolism and mitochondrial function
Novel pan-ERR agonists ameliorate heart failure through enhancing cardiac fatty acid metabolism and mitochondrial function
Jean C. Bopassa, MS, PhD, FAHA
Jean C. Bopassa, MS, PhD, FAHA
University of Texas, USA
02:40 pm US CST
Mic60, a New Player in Cardioprotection
Mic60, a New Player in Cardioprotection
Xi Fang, PhD
Xi Fang, PhD
University of California, San Diego, USA
02:55 pm US CST
Unveiling DELE1-HRI-eIF2a signaling in mitochondrial cardiomyopathy
Unveiling DELE1-HRI-eIF2a signaling in mitochondrial cardiomyopathy
Session 5 : Career development & 5MReSPARKS competition
Session 5 : Career development & 5MReSPARKS competition
Moderators
Moderators
Sarojiini Singh, PhD
Sarojiini Singh, PhD
University of Alabama at Birmingham, USA
Justin Bridges, PhD Student
Justin Bridges, PhD Student
University of Alabama at Birmingham, USA
Zamaneh Kassiri, PhD
Zamaneh Kassiri, PhD
University of Alberta, Canada
03:10 pm US CST
Graduate school: To Do or Not To Do?
Graduate school: To Do or Not To Do?
Break
Break
Introduction to 5MReSPARKS competition
Introduction to 5MReSPARKS competition
3:50 - 3:54 pm US CST
Postdoctoral/Research Associate Category
Postdoctoral/Research Associate Category
Lin Piao, Senior Research Professional
Lin Piao, Senior Research Professional
University of Chicago, USA
03:54 - 04:01 pm CST
Critical Role of Dynamin-Related Protein 1 (Drp1) in Regulating Mitochondrial Calcium Homeostasis During Myocardial Ischemia/Reperfusion Injury
Critical Role of Dynamin-Related Protein 1 (Drp1) in Regulating Mitochondrial Calcium Homeostasis During Myocardial Ischemia/Reperfusion Injury
Abhay Srivastava, PhD
Abhay Srivastava, PhD
University of Manitoba, Canada
04:02 - 04:09 pm CST
Development of iPSC-based clinical trial selection platform for patients with inherited metabolic and cardiovascular disorders
Development of iPSC-based clinical trial selection platform for patients with inherited metabolic and cardiovascular disorders
Xisheng Li, PhD
Xisheng Li, PhD
Icahn School of Medicine at Mount Sinai, USA
04:10 - 04:17 pm CST
Extracellular Vesicles in Cardiovascular Nanomedicine
Extracellular Vesicles in Cardiovascular Nanomedicine
Qin Zhang, Research Associate
Qin Zhang, Research Associate
University of Chicago, USA
04:18 - 04:25 pm CST
MMP3 Mediated Cardiac Ischemia-Reperfusion Injury through B1R-Dependent Mechanisms
MMP3 Mediated Cardiac Ischemia-Reperfusion Injury through B1R-Dependent Mechanisms
Rachel A Warren, Research Associate
Rachel A Warren, Research Associate
Nova Scotia Health, Canada
04:26 - 04:33 pm CST
Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type two diabetes: the ADVANCE study
Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type two diabetes: the ADVANCE study
Graduate Category
Graduate Category
Sushrut D Shah, PhD student
Sushrut D Shah, PhD student
Thomas Jefferson University, USA
04:36 - 04:43 pm CST
Effects of Allosteric Modulators on β-adrenergic receptors
Effects of Allosteric Modulators on β-adrenergic receptors
Harish Babu Kolla, Graduate student
Harish Babu Kolla, Graduate student
Dalhousie University, Canada
04:44 - 04:51 pm CST
Expanding CD19 CAR T Cell Therapy for Targeted Autoimmune Disease Treatment: Implications for Heart Conditions
Expanding CD19 CAR T Cell Therapy for Targeted Autoimmune Disease Treatment: Implications for Heart Conditions
Georges Tannous, Master's student
Georges Tannous, Master's student
Université de Montréal, Canada
04:52 - 04:59 pm CST
Sex Differences in the Small Conductance Calcium-Activated Potassium (SK) Current in the Predisposition of Males to Atrial Fibrillation
Sex Differences in the Small Conductance Calcium-Activated Potassium (SK) Current in the Predisposition of Males to Atrial Fibrillation
Beatrice Motok, Master's student
Beatrice Motok, Master's student
Université de Montréal, Canada
05:00 - 05:07 pm CST
Atrial remodeling during pregnancy in mice
Atrial remodeling during pregnancy in mice
Huixian Li, PhD student
Huixian Li, PhD student
The Chinese University of Hong Kong, Hong Kong
05:08 - 05:15 pm CST
Type 2 cytokines attenuate obesity-associated vascular dysfunction via myeloid IL-4Rα signaling
Type 2 cytokines attenuate obesity-associated vascular dysfunction via myeloid IL-4Rα signaling
Page updated
Google Sites
Report abuse